Results 31 to 40 of about 10,182 (138)

Tetrahydrobiopterin in phenylketonuria: Who can benefit? [PDF]

open access: yes, 2020
Phenylketonuria, abbreviated PKU, is a rare inherited metabolic disease. In this disease, a building block of protein (an amino acid) called phenylalanine cannot be converted to tyrosine. This results in high phenylalanine concentrations in blood and brain. If left untreated, this especially results in severe developmental delay as well as epilepsy and
openaire   +2 more sources

The Intricate Mechanism of Nitric Oxide Synthase

open access: yesJournal of Computational Chemistry, Volume 47, Issue 17, 30 June 2026.
The mechanism for NO formation by Nitric Oxide Synthase (NOS) has been studied using accurate DFT methods. A long‐range electron transfer from the cofactor H4B leads to formation of H2O2. ABSTRACT The biological formation of NO is performed by nitric oxide synthase.
Per E. M. Siegbahn
wiley   +1 more source

Impact of Gut Microbiota Metabolites on Serotonin Levels in Irritable Bowel Syndrome

open access: yesGut Medicine, Volume 2, Issue 2, Page 98-111, June 2026.
ABSTRACT Gut microbiota and their metabolites have been proposed as possible etiological factors in irritable bowel syndrome (IBS), and studies suggest that IBS is associated with impaired serotonin synthesis and release. Microbial metabolites are produced through biological pathways and enzymatic processes via gut microbiota.
Ning Gao   +7 more
wiley   +1 more source

Endothelial Integrin‐Linked Kinase (ILK) Deficiency Promotes Endothelial Activation and Cardiovascular Dysfunction via Receptor Interacting Protein Kinase‐1 (RIPK1) Enriched‐Extracellular Vesicle Signalling

open access: yesJournal of Extracellular Vesicles, Volume 15, Issue 6, June 2026.
Endothelial ILK loss drives RIPK1‐enriched EVs that propagate systemic endothelial activation and cardiovascular remodelling. EV cargo remodelling induces early endothelial injury, microvascular dysfunction and chronic cardiac alterations through a RIPK1 dependent pathway.
Alberto Cook‐Calvete   +9 more
wiley   +1 more source

Tetrahydrobiopterin, superoxide, and vascular dysfunction [PDF]

open access: yesFree Radical Biology and Medicine, 2009
(6R)-5,6,7,8-Tetrahydrobiopterin (BH(4)) is an endogenously produced pterin that is found widely distributed in mammalian tissues. BH(4) works as a cofactor of aromatic amino acid hydroxylases and nitric oxide synthases. In the vasculature a deficit of BH(4) is implicated in the mechanisms of several diseases including atherosclerosis, hypertension ...
openaire   +2 more sources

Maintenance of cellular tetrahydrobiopterin homeostasis

open access: yesBMB Reports, 2010
Tetrahydrobiopterin (BH4) is a multifunctional cofactor of aromatic amino acid hydroxylases and nitric oxide synthase (NOS) as well as an intracellular antioxidant in animals. Through regulation of NOS activity BH4 plays a pivotal role not only in a variety of normal cellular functions but also in the pathogenesis of cardiovascular and ...
Hye-Lim, Kim, Young Shik, Park
openaire   +3 more sources

Tetrahydrobiopterin and inherited hyperphenylalaninemias.

open access: yesThe Turkish journal of pediatrics, 1996
Tetrahydrobiopterin deficiency, a variant of hyperphenylalaninemia, may be caused by deficiency of one of the following enzymes: guanosine triphosphate cyclohydrolase 1,6-pyruvoyltetrahydropterin synthase, dihydropteridin reductase and pterin-4a-carbinolamine dehydratase.
Blau N, Thony B, Spada M, Ponzone A
openaire   +3 more sources

Structural and mechanistic insights into the divergence of pterin deaminase and sepiapterin deaminase. [PDF]

open access: yesAppl Microbiol Biotechnol
Shanmuganathan N   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy